ArticleJTO clinical and research reports2021

Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in

Azam Ghafoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.